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Pﬁesteria piscicida Steidinger & Burkholder is
a dinoflagellate that has been the cause of
serious concerns regarding both environmen-
tal and human health since its discovery in
the Albemarle–Pamlico estuarine ecosystem
in North Carolina and in the Chesapeake Bay
in Maryland (1). Subsequent discovery and
positive identification of this organism in
other eastern seaboard states has only height-
ened these concerns (2). Information on the
organism and its growth patterns and life
cycle has been published previously (3). Still,
there remains very little chemical information
regarding the biologically active compounds
produced by or associated with the organism.
There is evidence of neurotoxicity as well as
causality for severe skin damage (1,4–6).
However, a direct link of Pﬁesteria-produced
metabolites to these symptoms has been ham-
pered by the inability of investigators to iso-
late and chemically characterize such
compounds from cultured algae.
Chemical isolation from Pﬁesteria cultures
has proven to be a difﬁcult challenge for sev-
eral reasons. First, in any natural product iso-
lation scheme, there is a paucity of literature
upon which to base an experimental protocol.
Research scientists are constrained to use anec-
dotal reports, secondary literature, and even
personal observations as their guide. Second,
in the case of Pﬁesteria, the matters are com-
plicated further because biological activity is
often lost over short periods of time, presum-
ably because oxidative degradation, assay mis-
function, or perhaps permanent binding to
chromatographic solid support media. This
behavior appears to be a departure from the
typical behavior of toxins derived from other
dinoﬂagellates. Many of these toxins, such as
okadaic acid, saxitoxin, and the brevetoxins,
can often be stabilized or are stable enough of
their own accord to isolate, purify, and market
commercially (7). Third, P. piscicida appears
to secrete or release (8) the majority of its
active substance(s) rather than sequestering
them internally, as is more usual in dinoﬂagel-
lates. This external release of metabolites exac-
erbates the isolation and puriﬁcation problem.
Extraction processes designed to isolate highly
polar organic compounds from natural seawa-
ter (SW) or highly ionic culture medium
often have poor reproducibility because of the
multiple and constantly varying matrices pre-
sent. These matrices can be in the form of nat-
ural oils, agricultural runoff, petroleum wastes,
and so forth. Many organic compounds can
be found in SW at any given time. In the case
of laboratory Pﬁesteria culture, puriﬁcation of
active metabolites is just as complicated, as
currently used conditions require the presence
of ﬁsh to induce toxicity. Extraction processes
dealing with P. piscicida must deal with every-
thing associated with the fish, including
microorganisms and the secondary metabo-
lites they may produce. Such a complexity of
varying matrix with potential of a short-lived
biological activity can prove quite a challenge
to a natural products isolation program.
Adding to the difficulty of isolating and
purifying toxins from Pfiesteria are the
divergent leads and implications found in the
literature on isolation of biologically active
metabolites from this alga. In one of the earli-
est abstracts from the Society of Toxicology
on P. piscicida metabolites, the major toxic
activity was described as hydrophobic
(lipophilic) (9). This report described highly
lipophilic active components with molecular
weights of 16,000–20,000 atomic mass units
(amu) being excreted into the water. This
information would suggest that the target
molecule(s) are proteinaceous, requiring very
different purification schemes from those
used for smaller secondary metabolites. In
both cases, the collective results would target
the lipophilic portions of Pﬁesteria extract as
the source of activity and in turn would indi-
cate a purification protocol very different
from that used for larger proteins or polar
metabolites. In his article in Science News,
Mlot recorded Baden and Rein’s support for
a lipophilic active substance (10). They
reported that this crystalline lipophilic mater-
ial demonstrated the same symptoms, includ-
ing notable skin damage, as those found in
wild Pﬁesteria events.
In contrast, our own research has yielded
Pfiesteria-produced biological activity from
only the polar extracts as opposed to the
lipophilic-soluble active metabolites. This
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active polar component adds another
dimension to the purification scheme, mak-
ing the situation appear even more challeng-
ing. Mass spectrometric analyses of partially
puriﬁed active extracts have yielded no mass
data over 500 amu, disallowing any proteins
in our findings. The divergent paths listed
above describe a situation that covers the
entire range of polarity as well as molecular
size and type (proteins to small secondary
metabolites). This divergence highlights the
critical need to ensure that all involved labo-
ratories are using similar extracts derived
from the same organism. The current situa-
tion may lead one to believe that different
strains or perhaps completely different
organisms are being studied under the name
P. piscicida. The reported data and findings
also highlight the great complexity sur-
rounding basic research on P. piscicida and
its putative toxins.
The intent of this article is to provide
current information on putative toxins on the
basis of our own research ﬁndings related to
the toxic metabolites derived from Pfiesteria
extracts.
Materials and Methods
Cultures
Culture vessels were ﬁlled with 15 psu salinity
water (Instant Ocean, Aquarium Systems,
Mentor, OH, USA). The water was continu-
ally ﬁltered and aerated, and each culture ves-
sel was maintained for 14 days before adding
three tilapia. Fish were acclimated for 7 days
to ensure viability and were fed daily with
several flakes of Tetra Marin (Tetra, pur-
chased at a local Pet Warehouse store) fish
food. To this was added the Pﬁesteria inocu-
lum. After being tested as repeatedly lethal to
tilapia, the species identification of the
dinoflagellates was again verified from the
fish-killing cultures using scanning electron
microscopy of suture-swollen cells (11). The
ammonia and pH levels were monitored
carefully throughout the culturing process.
Mass Culture Harvest 
Culture water (300 L) containing Pfiesteria
cells was removed from the culturing tanks
at North Carolina State University in
Raleigh, North Carolina, and sent frozen to
the Marine Biotoxins Center in Charleston,
South Carolina. This culture was passed
through a Whatman GF/B glass fiber filter
(Whatman International Ltd., Maidstone,
UK) using vacuum filtration to effectively
separate the unlysed Pﬁesteria cell mass from
the culture medium (SW/Instant Ocean).
Both the cell mass (CM) as well as the
filtered SW medium were then processed
separately for subsequent extraction workup
and testing.
Extraction of Mass Cultures
Figure 1 demonstrates the basic fractionation
scheme for the initial partitioning of Pﬁesteria
cultures. Cells collected on the GF/B glass-
ﬁber ﬁlters were placed into a beaker and lysed
in 500 mL cold (0°C) methanol (MeOH)
using a Branson model 450 sonicator (Branson
Ultrasonics Corp., Danbury, CT, USA) ﬁtted
with a microprobe. Sonication was carried out
for 3–5 min at full power to ensure complete
cell lysis. The resultant methanolic solution
was then decanted, centrifuged, and filtered
though a 0.22-µm filter (GHP Acrodisc;
Gelman Sciences, Ann Arbor, MI, USA) to
remove any remaining cell debris and other
particulates. The ﬁltered extract was concen-
trated on a rotary-evaporator (Büchi RE121,
Büchi Labortechnik AG, Flawil, Switzerland)
and then fractionated via glass long-column
chromatography over 100-Å pore size silica
gel. Five sequential fractions were eluted
using an elutropic solvent gradient series of
increasing polarity. This elutropic series used
ethyl acetate (EtOAc), MeOH, and water to
effectively partition the extract over the full
range of solute polarity. Fractionation was
assisted by positive nitrogen gas pressure
applied to the top of the glass column. Each
fraction (CM 1–5) was then dried ﬁrst using
rotary evaporation (35°C), then under high
vacuum overnight to remove any residual
water. The fractions were subsequently sub-
mitted for bioassay analysis (below) as well
as for chemical analysis using mass
spectrometry (MS) and nuclear magnetic res-
onance spectroscopy (NMR).
Extraction of the Seawater Medium
The spent SW culture medium was extracted
using a large glass column (6˝ diameter, 12˝
length, 4-L capacity) charged with C18
(100 Å) reverse-phase solid support. The C18
was conditioned with MeOH and rinsed with
deionized water prior to operation. The SW
media was passed through the C18 column
followed by a deionized water rinse to remove
all excess sea salts. The organic compounds
adsorbed to the C18 solid support were
eluted first with MeOH, then EtOAc. Both
organic fractions tested positive in the battery
of assays (below). The organic washes were
combined and concentrated using rotary
evaporation (35°C) followed by subsequent
high-vacuum drying overnight to remove any
remaining water. This dried fraction was
taken up in MeOH and passed through glass-
column chromatography using silica as the
solid phase in a fashion identical to that
described above for the CM extract. Five frac-
tions were generated paralleling those
obtained from the cell mass extract. The sam-
ple fractionation scheme for both CM
extracts and the SW medium is summarized
in Figure 1.
As a safety precaution, after the initial
extraction processes, both the remaining cell
debris and water were tested for any residual
activity using the battery of assays described
in the next section. In all cases after the
described extraction, they were found to be
negative and at this point were deemed safe
for disposal.
Assays
Determination of toxicity/biological activity
was performed on the 10 extracts (CM 1–5,
SW 1–5). This screening included a brine
shrimp bioassay, a cytotoxicity assay (12)
modiﬁed for GH4C1 rat pituitary cells, a ﬁsh
bioassay, and a reporter gene assay (13,14).
The two cell-based assays were conducted as
published, whereas the ﬁsh and shrimp bioas-
says were developed in house solely for activ-
ity screening purposes. It is important to note
that active extracts are in very limited supply
and that the purpose of this work is to isolate
enough puriﬁed material for structural analy-
sis, not to evaluate assays used to guide frac-
tionation. It is the information gathered from
the entire battery of assays used that provides
bioassay-guided fractionation control. Assays
were chosen on the basis of observed activity.
These assays are described as follows:
Brine shrimp bioassay. The brine shrimp
bioassay was set up in the following fashion.
To reduce variability because of age of
Artemia, all assays were performed using
Artemia that were 16–20 hr old. The bioassay
was performed in 12-well plastic plates
(Corning Costar Corp., Cambridge, MA,
USA). Each well contained 1 mL 35 psu artiﬁ-
cial SW (Instant Ocean) in which 20 Artemia
were transferred from the hatching chamber.
Twenty microliters of each methanolic
Pfiesteria SW or CM extract was added for
each fraction obtained. The assay plate was
examined over a time course of 48 hr to deter-
mine both the number of dead and time of
death of the Artemia. Limited supply of active
extract prohibited any form of replication.
Fish bioassay. The fish bioassays were
performed in 24-well plastic plates (Corning
Costar). Each well contained 2 mL 15 psu
Figure 1. Fractionation scheme used for both CM and
SW medium extracts of P. piscicida.
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seawater in which 1 juvenile sheepshead
minnow (Cyprinodon variegatus) 7–10 days of
age was placed. Twenty microliters of
methanolic Pﬁesteria SW or CM extract was
added for each fraction tested. The assay plate
was examined over a time course of 48 hr at
room temperature to monitor ﬁsh behavior as
well as to record time of death.
Cytotoxicity assay (12). Cytotoxicity assays
(GH4C1 assay) are used as a first-tier screen
for toxic activity. Cytotoxicity was measured
by using a microtiter plate assay using the
mitochondrial indicator 3-(4,5-dimethylthia-
zol-2,5-diphenyl) tetrazolium bromide
(MTT) for an end point measurement.
GH4C1 cells (30,000 per well) were plated in
0.1 mL of appropriate media in 96-well tissue
culture plates (Corning Costar). The GH4C1
cell line is derived from rat pituitary cells. Test
samples (2 µL methanolic extract) were added
to each well and incubated for approximately
24 hr. Each fraction was analyzed in duplicate
with a 2-µL MeOH negative control used to
test the sample vehicle. After incubation,
15 µL MTT (5 mg/mL in phosphate-
buffered saline) was added to each well and
incubated for 4 hr at 37°C. Mitochondrial
dehydrogenases in live cells convert the MTT
to an insoluble formazan crystal, resulting in
a purple color. The crystals were solubilized
by the addition of 1% sodium dodecyl sulfate
in 0.1 N HCl and absorbance read at 570 nm
with a Titer Tek 96-well plate reader
(EFLAB, Helsinki, Finland). The plate reader
subtracts nonspecific absorbance by media
and nonconverted MTT to yield a corrected
absorbance value. 
GH4C1 reporter gene assay (13,14). The
luciferase reporter gene assay is currently used
as a second-tier screen for biological activity.
GH4C1 c-fos-luc transfected cells are seeded in
a 96-well clear-bottom white plate (Corning
Costar) at a density of 30,000 cells per well
and are allowed to incubate overnight to
ensure attachment. Cells were treated with
samples for 4 hr at 37°C. Experimental media
were then removed from wells and 20 µL of
cell lysis buffer was added. Lysis proceeded at
room temperature for 20 min, then the plates
were read in the luminometer (Lumistar,
BMG, Durham, NC, USA). Within the lumi-
nometer, each well was injected with 20 µL
luciferase and ATP (Luciferase assay reagent;
Promega, Madison, WI, USA), and the lumi-
nescence generated from each well was read
over a 10-sec interval. 
Gas chromatography–mass spectrometry,
liquid chromatography–mass spectrometry,
and nuclear magnetic resonance spectroscopy.
All semipurified and purified compounds
derived in our isolation schemes were submit-
ted for structural analysis and chemical char-
acterization using gas chromatography-MS
(GC-MS) (Finnigan Magnum Series;
Thermo Finnigan, San Jose, CA, USA);
liquid chromatography-MS (LC-MS) (Perkin-
Elmer Sciex Triple Quad Biomolecular Mass
Analyzer; Applied Biosystems, Foster City,
CA, USA) and nuclear magnetic resonance
(Bruker DMX 500; Bruker, Billerica, MA,
USA) as appropriate. Preparative puriﬁcation
of polar active compound(s) is currently
under way in efforts to generate enough
material for complete structural analysis of
the active compound(s).
Results
The main focus of the work described is the
use of a battery of bioassays to guide frac-
tionation in an effort to isolate, purify, and
structurally characterize the toxic compo-
nents of P. piscicida extracts. The extracts
used at the time this report was prepared
were not in a state of high purity. Multiple
assays were required to monitor for both
known and unknown activities (14) to guide
the fractionation process. Results determined
at this crude stage of the process are often in
error, as extracts contain many compounds
having multiple activities that often interfere
with a given assay. It must also be noted that
the very limited supply of active extract made
multiple testing in any given assay prohibi-
tive. In this light, each assay performed
maintained negative controls only for inter-
nal assessment of the assay’s function.
Because the toxin(s) have yet to be struc-
turally characterized and purified to an ana-
lytically pure state (without potential
interfering agents) and because Pﬁesteria rep-
resents a newly described organism, good
negative control extracts have been difficult
to define. It must again be noted that nega-
tive tests may be due simply to a poor choice
of assay, or that the concentration of the
active component is below detection limits.
The testing of proper controls with well-
deﬁned samples will ultimately be done once
we have a definitive handle on the bioactive
substance(s). To counter these difﬁculties, we
use a battery of assays and evaluate activity
based on a compilation of all the results. The
bioassay results reported in this article should
be evaluated with this in mind. They have
been generated on the basis of a simple posi-
tive/negative “hot or not” response. As multi-
ple replicates were not advisable because of
the limited supply of extract, error bars could
not be generated at this time.
GH4C1 Cytotoxicity Assay
The results of our general cytotoxicity assay
are summarized in Figure 2. In this graph,
fractions (F1–F5) are represented for both the
CM extracts and the SW culture medium.
Activity data in this assay clearly demonstrated
two distinct active fractions isolated from both
CM and SW. The lipophilic activity found in
fractions F1 and F2 was generally weak for
both sets (SW and CM) of fractions, though
it was usually stronger in the CM extracts
than the SW extracts. The polar fractions
demonstrating activity (F3, F4) were consis-
tently active in both sets but with a reversal of
relative strength with respect to the lipophilic
activity. That is, F3 SW and F4 SW fractions
were much more active than the correspond-
ing F3 and F4 obtained from the CM extract.
This result, in addition to the need to soni-
cate Pﬁesteria cells to cause cell lysis, gives cre-
dence to the claim that the dinoflagellate
may, in some fashion, excrete or secrete its
active metabolites into the water rather than
the more common dinoflagellate mode of
sequestering of toxins within the cell (8). We
have found when using small 1-L batch cul-
tures that biological activity varies greatly
from culture to culture of the same Pﬁesteria
strain. Because of this, and because we are
interested only in isolating a toxic molecule
from these cultures, only relative hot or not
data are reported in the bioassay guided frac-
tionation steps. All data are relative to an SW
vehicle negative control. It is noteworthy that
even though activity was reduced or elimi-
nated in time, the F1–F5 fractions in both
sets of data remained relatively consistent in
their activity proﬁles both over time and from
culture batch to batch.
The combined active CM lipophilic
fractions, F1 and F2, were further purified
over silica gel normal-phase high-perfor-
mance liquid chromatography (HPLC). This
yielded an analytically pure oily substance
(determined by MS and NMR). The struc-
ture of this compound was determined by
GC-MS (Finnigan) and NMR (Bruker DMX
500 MHz, Bruker). It was identified as
di(2-ethylhexyl)phthalate (DEHP), a com-
mon plasticizer and known ichthyotoxin and
endocrine disrupter (15). Other common
phthalates have also been observed and iden-
tified from the lipophilic fractions, but to
date these have represented insignificant
quantities compared with DEHP. Phthalic
esters are very commonly found in signiﬁcant
amounts in solvents and are used as plasticiz-
ers in plastic containers. They can be found
virtually anywhere as contaminants (15).
However, finding them in our Pfiesteria
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Figure 2. Results of the cytotoxicity assay on CM and
SW extracts. Activity reported is relative to negative
MeOH controls.
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extracts in such large quantities was quite
surprising. We use only glass columns and
precleaned support materials, as well as redis-
tilled solvents free of contamination (GC
grade). As such, we felt that our extraction
methodology simply could not account for up
to 10–20 mg of extracted DEHP from just 15
L of culture. This necessitated a search for the
source of DEHP. We feel certain that we have
identiﬁed the major source for this contami-
nant and determined it as the artiﬁcial seawa-
ter (Instant Ocean) used in preparing the
culture medium. It is likely that the process
used in making or packaging Instant Ocean
uses many plastic components, which in turn
could provide the source of the phthalate
ester. To demonstrate this, 45 g Instant
Ocean salts were extracted with 150 mL of
highly pure chloroform (redistillation fol-
lowed by GC-MS analysis to demonstrate
phthalate-free conditions). After removing the
solvent, the residual oil, approximately 35 mg,
was analyzed with GC-MS and NMR.
Analysis confirmed large amounts of DEHP
present in these salts. (Conformational spec-
tral data shown in Figure 3A, B.) We feel that
this ﬁnding is very important and should be
noted by all laboratories when testing fractions
isolated from any matrix associated with
Instant Ocean. Because of the variability of
the DEHP concentration found in Instant
Ocean, the culturing process we used has
reverted from culturing with Instant Ocean to
culturing with filtered Gulf Stream water
obtained off the coast of North Carolina. 
Brine Shrimp Bioassay
This assay also demonstrated two active
areas, based on chromatographic partitioning
(Figure 4). It should be noted that there was
a great deal of variability in the levels of
activity from batch to batch. This could be
observed in activity profiles of the brine
shrimp assay; in some cases low activity
could be seen in F1 and F2 fractions and in
other cases there would be no activity. The
activity found in F1 and F2 in both CM and
SW appears to be due predominantly to
DEHP, as we have observed no killing
behavior in this assay when testing these
extracts after removal of the phthalate esters
by silica gel HPLC. The brine shrimp
demonstrated a high degree of sensitivity to
DEHP. However, the susceptibility of the
brine shrimp to the phthalic ester was con-
siderably weaker compared to the activity
found in the more polar F3 and F4. These
later fractions obtained from both CM and
SW were consistently lethal to Artemia with
every culture batch tested.
Fish Bioassay
Fish time-of-death data are summarized in
Figure 5. The fractions containing DEHP
have indicated low-level activity in this assay,
as the literature has suggested (13). As in the
brine shrimp bioassay, variability in activity
could be seen from culture batch to batch.
However, we observed very strong ichthyo-
toxicity with fractions F3–F5, with F3 often
causing fish death in less than 1 hr. In this
assay the SW extracts F3–F5 were much
more potent than the corresponding CM
extracts, although relative activity proﬁles in
parallel fractions was similar. 
An interesting response of the F3 and F4
fractions was observed upon dilution. In non-
lethal doses of extract or in diluted F3 and F4
fractions, the fish would invert and appear
dead, only to revive within 12 hr to an appar-
ent normal state. This phenomenon is also
quite common from extracts derived from
weakly active culture. No explanation for this
behavior has been determined at this time.
GH4C1 Reporter Gene Assay
For both sets of fractions (CM and SW), F3,
F4, and in some cases F5, were active on the
reporter gene assay (Figure 6). Variability in
the levels of activity is easily accounted for by
the crude fractionation (i.e., only five large
Figure 3. (A) Conﬁrmatory 1H- and 13C-NMR spectra of CM-/SW-derived DEHP. Spectra are identical to those obtained with commercially available DEHP. (B) GC-MS spectra of
puriﬁed DEHP from the lipophilic fractions F1 CM and F2 CM. The M+1 parent ion at 390 and the characteristic phthalate fragment ion at 149 are characteristic of DEHP.
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Figure 4. Brine shrimp assay results for CM and SW
F1–F5 obtained from P. piscicida extracts.
Figure 5. Sheepshead minnow fish bioassay on the
same SW and CM fractions used in the brine shrimp and
cell cytotoxicity assays.
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fractionation samples). Only F3 consistently
demonstrated strong activity from CM
extracts. This is most likely due to lower con-
centrations of the polar activity associated
with the cell. The small induction of fractions
F1 and F2 has generally been attributed to
phthalate esters, particularly DEHP.
Discussion
We determined that the extracts of mass-
cultured P. piscicida can yield two distinctive
biological activities on the basis of polarity of
the metabolite isolated. The nonpolar
(lipophilic) fractions F1 and F2 consistently
contained high concentrations of DEHP, a
man-made phthalate ester commonly used in
plastics as a plasticizer. Often the levels of
phthalates in these fractions were able to kill
shrimp and fish as well as give positive
responses in the cytotoxicity assay and reporter
gene assay. We have determined that the prin-
cipal source of DEHP (and other phthalates) in
these extracts is from the Instant Ocean used to
make up the seawater medium. The compound
DEHP was identiﬁed and conﬁrmed through
the use of GC-MS and NMR. After DEHP
and other minor phthalates have been removed
from these fractions via silica chromatography,
we observed no other lipophilic biological activ-
ity from either set of extracts (CM, SW) in our
battery of assays. We have also been unable to
generate any lipophilic crystalline materials
described in other reports or to isolate any
excreted biologically active lipophilic proteina-
ceous compounds from cultured Pfiesteria
extracts as reported by others.
The more polar (hydrophilic) fractions,
derived from the SW extracts (F3, F4, and
sometimes F5), contained a compound(s)
that induced the GH4C1 reporter gene assay,
demonstrated cytotoxicity in the GH4C1
assay, and killed both brine shrimp and ﬁsh.
The F3 and F4 fractions obtained from the
CM extracts of this strain induced the
reporter gene assay, but only fraction F3
demonstrated any lethality to brine shrimp
and occasionally fish. These fractions
demonstrated activity in the GH4C1 cytotox-
icity assay as well, although generally the
responses were weak. We believe that the
variability in assay response between CM and
SW extracts could be due simply to a con-
centration effect, demonstrating that the
active substance(s) is preferentially released
from the cell rather than sequestered in any
significant amounts. We believe that the
polar fractions F3 and F4 from CM and SW
probably represent the same compound or
family of compounds. Preliminary LC-MS,
NMR, and photo diode array-LC data (not
shown) have yet to show any signiﬁcant dif-
ferences in the makeup of F3 and F4. This
certainly does not rule out distinct toxic
substances in each, however.
Currently, large-scale mass culturing is
under way to provide sufﬁcient quantities of
active fractions F3 and F4 for further chemical
and structural analysis.
Summary
Our research has yielded only polar, water-
soluble components as the active substances
contained in toxic P. piscicida cultures. We
have observed no biologically active protein
production and the active compound(s) we
do observe exhibit molecular weights below
1,000 amu (16). Furthermore, after many
trials, we have been able to isolate no
lipophilic or hydrophilic chemical extract
that will cause the formation of lesions in a
fish bioassay. In fact, we can produce only
minor lipophilic activity at all, and can pro-
duce no nonpolar crystalline materials, even
from very large culture volumes. These
apparent incongruities highlight the need to
replicate extraction procedures in multiple
laboratories to verify results. They also
emphasize the need for care in identifying
the alga species used in toxin production.
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Figure 6. Reporter gene assay results for the same SW
and CM fractions used for the brine shrimp and fish
bioassays.
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